• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Mirion Technologies Inc.

    1/23/25 4:18:56 PM ET
    $MIR
    Industrial Machinery/Components
    Industrials
    Get the next $MIR alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001486259
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Mirion Technologies, Inc.
    SEC File Number
    001-39352
    Address of Issuer
    1218 MENLO DRIVE
    ATLANTA
    GEORGIA
    30318
    Phone
    (770) 432-2744
    Name of Person for Whose Account the Securities are To Be Sold
    Logan Thomas D
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Former Affiliate

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    UBS Financial Services, Inc.
    1000 Harbor Blvd
    3rd Floor
    Weehawken � NJ � 07086
    7500133050.0022550009401/23/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common06/28/2022GiftThomas LoganCheckbox checked03/31/2015750006/28/2022NA

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    Aere Perennius LLC
    1218 MENLO DRIVE
    Atlanta � GA � 30318
    Common10/24/20247500105815.25
    Aere Perennius LLC
    1218 MENLO DRIVE
    Atlanta � GA � 30318
    Common11/25/20247500124447.50
    Aere Perennius LLC
    1218 MENLO DRIVE
    Atlanta � GA � 30318
    Common12/23/20247500132957.00

    144: Remarks and Signature

    Remarks
    The shares represented in this filing are being sold under Aere Perennius LLC. Aere Perennius LLC was formerly affiliated with Thomas Logan, as CEO of the Issuer.
    Date of Notice
    01/23/2025
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    02/27/2024

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ UBS Financial Services Inc, as attorney-in-fact for Mary Logan Martineau

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $MIR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MIR

    DatePrice TargetRatingAnalyst
    12/19/2024$22.00Outperform
    Robert W. Baird
    9/26/2024$14.00Buy
    B. Riley Securities
    5/26/2023$11.00Buy
    Citigroup
    3/24/2022$13.00Market Outperform
    CJS Securities
    11/29/2021$14.00Buy
    Goldman Sachs
    10/25/2021$14.00Buy
    Citigroup
    More analyst ratings

    $MIR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mirion Announces First Quarter 2025 Financial Results and Updates Full Year Guidance

      Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA

      4/29/25 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Earnings Release and Conference Call Date for First Quarter 2025

      Mirion (NYSE:MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with acces

      4/21/25 8:15:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software

      Apex-Guard™ Software Version 1.2 Introduces Robust Impurity Analysis for Enhanced Radioisotope Quality Mirion Technologies (NYSE:MIR), a global provider of advanced radiation safety solutions, today announced the latest release of its Apex-Guard gamma spectroscopy software. Tailored to meet the stringent regulatory demands of commercial radioisotope producers, Apex-Guard software V1.2 significantly enhances the Mirion solutions suite within the radiopharmaceutical supply chain with a robust impurity analysis for radioisotope producers. This software release reinforces the Mirion commitment to improving quality in cancer care, through focused innovation across its Mirion Technologies and Mi

      4/1/25 4:03:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Schopfer Brian covered exercise/tax liability with 14,801 shares, decreasing direct ownership by 2% to 883,427 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      4/3/25 4:26:18 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Chief Executive Officer Logan Thomas D covered exercise/tax liability with 54,143 shares, decreasing direct ownership by 1% to 3,943,501 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      4/3/25 4:24:25 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Chief Human Resources Officer Ulrich Alison covered exercise/tax liability with 2,859 shares, decreasing direct ownership by 8% to 35,230 units (SEC Form 4)

      4 - Mirion Technologies, Inc. (0001809987) (Issuer)

      4/3/25 4:22:48 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Financials

    Live finance-specific insights

    See more
    • Mirion Announces First Quarter 2025 Financial Results and Updates Full Year Guidance

      Revenues for the first quarter increased 4.9% to $202.0 million, compared to $192.6 million in the same period in 2024. GAAP net income was $0.4 million in the first quarter, compared to a GAAP net loss of $26.5 million in the same period in 2024; a 102% improvement. Adjusted EBITDA was $46.7 million in the first quarter, an 18% increase from $39.5 million in the same period last year. GAAP net earnings per share in the first quarter was $0.00, compared to a GAAP net loss per share of $0.13 in the same period in 2024. Adjusted earnings per share for the quarter was $0.10, compared to $0.06 in the same period in 2024. The company reaffirmed 2025 Organic Revenue growth, Adjusted EBITDA

      4/29/25 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Earnings Release and Conference Call Date for First Quarter 2025

      Mirion (NYSE:MIR) announced today that it will release financial results for first quarter 2025 after market close on Tuesday, April 29, 2025. Following the news release, the company will host a conference call the next day, Wednesday, April 30, 2025, at 11:00 am ET to discuss the results. Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events. A telephonic replay will be available shortly after the conclusion of the call and until May 14, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with acces

      4/21/25 8:15:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Announces Record Fourth Quarter and Record Full Year 2024 Financial Results; Reaffirms Full Year 2025 Guidance

       Revenues for the fourth quarter increased 10.4% to $254.3 million, compared to $230.4 million in the same period in 2023. GAAP net income was $15.9 million in the fourth quarter, compared to a GAAP net loss of $14.5 million in the same period last year; a 210% improvement. Adjusted EBITDA was $69.6 million, a 14.1% increase from $61.0 million in the same period last year. GAAP net earnings per share in the fourth quarter was $0.07, compared to a GAAP net loss per share of $0.08 in the fourth quarter of 2023. Adjusted earnings per share for the quarter was $0.17, compared to $0.15 in the same period last year. The company reaffirmed its full year 2025 guidance provided at the Dece

      2/11/25 4:05:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Robert W. Baird initiated coverage on Mirion Technologies with a new price target

      Robert W. Baird initiated coverage of Mirion Technologies with a rating of Outperform and set a new price target of $22.00

      12/19/24 7:44:58 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • B. Riley Securities initiated coverage on Mirion Technologies with a new price target

      B. Riley Securities initiated coverage of Mirion Technologies with a rating of Buy and set a new price target of $14.00

      9/26/24 7:38:28 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Citigroup resumed coverage on Mirion Technologies with a new price target

      Citigroup resumed coverage of Mirion Technologies with a rating of Buy and set a new price target of $11.00

      5/26/23 7:18:55 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Mirion Technologies Inc.

      SC 13G/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/14/24 1:28:33 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Mirion Technologies Inc.

      SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/13/24 6:42:31 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Mirion Technologies Inc.

      SC 13D/A - Mirion Technologies, Inc. (0001809987) (Subject)

      11/6/24 6:59:38 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    SEC Filings

    See more
    • SEC Form 10-Q filed by Mirion Technologies Inc.

      10-Q - Mirion Technologies, Inc. (0001809987) (Filer)

      4/30/25 4:21:46 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Mirion Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Mirion Technologies, Inc. (0001809987) (Filer)

      4/29/25 4:21:26 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • SEC Form DEFA14A filed by Mirion Technologies Inc.

      DEFA14A - Mirion Technologies, Inc. (0001809987) (Filer)

      4/1/25 4:44:03 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials

    $MIR
    Leadership Updates

    Live Leadership Updates

    See more
    • Sun Nuclear® Solutions Supporting Better Patient Care in Focus at ASTRO 2023

      SunCHECK® Platform Enhancements, New MRgRT QA Solutions, and More MELBOURNE, Fla., Sept. 29, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (NYSE:MIR), will showcase enhancements and additions to its comprehensive Quality Management portfolio at the ASTRO Annual Meeting, October 1-3, in San Diego, California. The Sun Nuclear booth (#1835) will highlight new features and insights for the SunCHECK® Platform, new MR capabilities for proven SRS/SBRT QA solutions, and the new SIM+™ Pro laser system for patient alignment. Complete Quality Management in One PlatformAvail

      9/29/23 4:15:00 PM ET
      $MIR
      Industrial Machinery/Components
      Industrials
    • Janus International Appoints David Vanevenhoven as Chief Accounting Officer

      Brings over 15 years of accounting and M&A auditing experience to further enhance Janus's financial reporting and integration capabilities Janus International Group, Inc. (NYSE:JBI) ("Janus" or the "Company"), a leading provider of cutting-edge access control technologies and building product solutions for the self-storage and other commercial and industrial sectors, today announced the appointment of David Vanevenhoven as Chief Accounting Officer, on February 20, 2023. He will report directly to Janus's CFO, Anselm Wong. Mr. Vanevenhoven brings over 15 years of experience in financial accounting and auditing to oversee Janus's accounting function, financial reporting, and internal control

      2/21/23 7:00:00 AM ET
      $JBI
      $MIR
      Building Products
      Industrials
      Industrial Machinery/Components
    • Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

      Mirion Technologies, Inc. ("Mirion," "we" or the "Company") (NYSE:MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion's CEO, Tom Logan, who had been acting as President of the business segment. Michael joins Mirion from Novartis, where he most recently served as the Head of Radioligand Imaging for the Advanced Accelerator Applications business. Prior to Novartis, Michael spent five years at Jubilant Pharma where he served in several different roles with increasing le

      10/3/22 8:00:00 AM ET
      $MIR
      Industrial Machinery/Components
      Industrials